Across TCGA pan-cancer cohorts, DCUN1D5 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated DCUN1D5 data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.
The strongest signal is observed in brain lower grade glioma (LGG), where higher DCUN1D5 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated DCUN1D5 expression acts as an unfavorable survival marker.
LGG are the cancer types where DCUN1D5 Mutation most reproducibly stratifies survival.